说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 句库 -> 血浆凝血酶原
1.
Application of deception of Plasma facer Ⅱ coagulant activity by echis carinatus venom chromogenic substrateSubstray in the diagnosis of hepatic desease
巨齿蛇毒发色底物法检测血浆凝血酶原活性在肝病诊断中的应用
2.
Relationship of Child-Pugh class with plasma prothrombin time and serum liver fibrosis indexes in patients with cirrhosis
肝硬化患者血浆凝血酶原时间和血清肝纤维化指标与Child-Pugh分级的关系
3.
plasma throml oplastin antecedant (PTA)
血浆促凝血酶原激酶前体
4.
A plasma protein that is converted into thrombin during blood clotting.
凝血原酶一种血浆蛋白质,在血液凝聚时转化成凝血酵素
5.
tissue thromboplasti
组织促凝血酶原激酶
6.
thromboplastin antecedent
促凝血酶原激酶先质
7.
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶,用于溶解血凝块的药物中
8.
Separation of Prothrombin Complex Concentrates from Plasma by Macroporous Anion-Exchange Resin
大孔阴离子交换树脂从血浆中分离凝血酶原复合物
9.
congenital aprothrombinemia
先天性凝血酶原缺乏症
10.
Use of EDTA Samples for Prothrombin time Measurement
使用EDTA抗凝血检测凝血酶原时间
11.
The precursor of any of various blood factors necessary for coagulation.
前凝血剂血液凝结所必须的凝血因子的凝血酶原
12.
Significance of Warfarin and PIVKA-Ⅱ s Plasma Concentration in Anticoagulation Monitoring Following Mechanical Heart Valve Replacment;
华法林和凝血酶原前体蛋白的血浆浓度在心脏机械瓣膜置换术后抗凝监测中的意义
13.
Thrombin clotting time measurement of plasma heparin and its clinical application
凝血酶法测定血浆肝素含量及其临床应用
14.
A Study on the Deficiency of Plasma PC Proteins and AT-Ⅲ in Chinese Patients with Budd-Chiari Syndrome;
布-加综合征血浆蛋白C、抗凝血酶-Ⅲ测定
15.
In contrast, there wag no abnormal prothrombin in the rat plasma during its liver regeneration.
诱癌早期的大鼠血浆即出现了高水平异常凝血酶原,它可用于肝癌的早期诊断。
16.
Prothrombin: Carbohydrate-protein compound in plasma essential to coagulation.
凝血原 :血浆中的一类碳水化合物糖蛋白,是凝血系统中的必要成分。
17.
A Study on the Effect of Platelet-rich Plasma, Activated by Different Concentrations of Thrombin, on the Repair of Cranial Defects;
不同浓度凝血酶对富血小板血浆促颅骨缺损修复影响的实验研究
18.
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系